New Opportunities for Bio-Pharma Industry in China After CFDA Joined ICH, Chinese-American Bio/Pharmaceutical Society
Scott Carter will speak on “Legal considerations for cross-border licensing deals” at the Chinese-American Bio/Pharmaceutical Society event “New Opportunities for Bio-Pharma Industry in China After CFDA Joined ICH” on August 25, 2018.
Disclaimer
Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
